We are live on ! Find out more
SRTA icon

Strata Critical Medical

105 hedge funds and large institutions have $89.1M invested in Strata Critical Medical in 2023 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 31 increasing their positions, 25 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 6

24% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 25

13% more funds holding

Funds holding: 93 → 105 (+12)

3.28% less ownership

Funds ownership: 49.69% → 46.41% (-3.3%)

36% less capital inflows, than outflows

Capital inflows: $14.4M | Capital outflows: $22.6M

45% less call options, than puts

Call options by funds: $802K | Put options by funds: $1.47M

Holders
105
Holders Change
+12
Holders Change %
+12.9%
% of All Funds
1.66%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
31
Reduced
25
Closed
6
Calls
$802​K
Puts
$1.47​M
Net Calls
-⁠$665​K
Net Calls Change
-⁠$127​K

SRTA Hedge Fund Activity: Q3 2023 in Review

105 of the 6,315 institutional investors tracked by Wall St. Rank reported a position in Strata Critical Medical (SRTA) for Q3 2023, worth a combined $89.1M — down 38% from $143M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new SRTA positions and 6 closed out — a net gain of 12 holders — while 31 added to existing stakes and 25 trimmed.

The largest buyer was Uniplan Investment Counsel, opening a new position worth an estimated $2.48M. The largest seller was HG Vora Capital Management, exiting entirely with an estimated $10.8M sold.

  • 105 institutional investors held Strata Critical Medical (SRTA) as of Q3 2023, up from 93 in Q2 2023.
  • Funds reported $89.1M of Strata Critical Medical stock for Q3 2023, down 38% quarter-over-quarter.
  • 18 funds opened new Strata Critical Medical positions in Q3 2023 and 6 closed out, a net change of +12 holders.
  • The largest Strata Critical Medical buyer in Q3 2023 was Uniplan Investment Counsel, an estimated $2.48M added.
  • The largest Strata Critical Medical seller in Q3 2023 was HG Vora Capital Management, an estimated $10.8M sold.

Based on aggregated 13F filings for Q3 2023.